Clinical Trials Directory

Trials / Conditions / Gastroesophageal Junction Carcinoma

Gastroesophageal Junction Carcinoma

11 registered clinical trials studyying Gastroesophageal Junction Carcinoma — 6 currently recruiting.

StatusTrialSponsorPhase
RecruitingStudying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays
NCT07283939
Alliance for Clinical Trials in OncologyN/A
RecruitingGivastomig Combined With Nivolumab and Chemotherapy in Adults With CLDN18.2 Positive Metastatic Gastric Cancer
NCT07432295
I-Mab Biopharma US LimitedPhase 2
RecruitingThe Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and
NCT07285044
Mayo ClinicPhase 2
RecruitingA Phase II Trial to Evaluate the Effect of Itraconazole on Pathologic Complete Response Rates in Resectable Es
NCT05563766
VA Office of Research and DevelopmentPhase 2
TerminatedA Study to Evaluate Nivolumab in the Treatment of Early Stage Esophageal or Gastroesophageal Cancer
NCT05780736
Bristol-Myers Squibb—
TerminatedA Study of SGN-ALPV in Advanced Solid Tumors
NCT05229900
Seagen Inc.Phase 1
RecruitingORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
NCT05059444
Guardant Health, Inc.—
RecruitingStudy of TJ033721 (Givastomig) in Subjects With Advanced or Metastatic Solid Tumors
NCT04900818
I-Mab Biopharma US LimitedPhase 1
TerminatedA Study of SGN-STNV in Advanced Solid Tumors
NCT04665921
Seagen Inc.Phase 1
TerminatedA Safety Study of SEA-TGT (SGN-TGT) in Advanced Cancer
NCT04254107
Seagen Inc.Phase 1
TerminatedCelecoxib/Oxaliplatin/Capecitabine for Gastric/Gastroesophageal Junction Carcinoma
NCT00256321
University of California, IrvinePhase 2